News
46m
Inquirer.net on MSNDOH: COVID vaccines remain effective vs new variantFilipinos who received a full dose of COVID-19 vaccines at the height of the pandemic from 2021 to 2023 are still protected ...
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.
One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results